Martha J. Demski
Ms. Demski has served on the Board of Directors since 2005 and was named Chair in June 2018. Ms. Demski also currently serves as a director of Adamas Pharmaceuticals, Inc., ADMA Biologics, Inc., and Equillium Inc., all of which are public biopharmaceutical companies where she chairs the audit committee and is a member of the compensation committee of all three companies. From 2011 to 2017, Ms. Demski served as Senior Vice President and Chief Financial Officer of Ajinimoto Althea, Inc., now known as Ajinomoto Bio-Pharma Services, a fully integrated contract development and manufacturing organization. From 2008 to 2010, she served as the Interim Chief Operating Officer and Chief Financial Officer of the Sidney Kimmel Cancer Center (SKCC), a non-profit corporation that engaged in biomedical research. Previously, Ms. Demski served as Vice President and Chief Financial Officer of Vical. Additionally, Ms. Demski has more than 13 years of banking experience with Bank of America.
Ms. Demski is a National Association of Corporate Directors Board Governance Fellow, and she received the Director of the Year in Corporate Governance award by the Corporate Directors Forum in 2017. Ms. Demski earned her B.A. from Michigan State University and an MBA from The University of Chicago Booth School of Business with concentrations in accounting and finance.